Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients - PubMed (original) (raw)
Comparative Study
. 2011 Jan 11;76(2):172-8.
doi: 10.1212/WNL.0b013e3182061b1e.
F Perez-Miralles, T Sevilla, N Muelas, M J Chumillas, F Mayordomo, I Azorin, E Carmona, F Moscardo, J Palau, L Jacobson, A Vincent, J J Vilchez, L Bataller
Affiliations
- PMID: 21220721
- DOI: 10.1212/WNL.0b013e3182061b1e
Comparative Study
Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients
I Rubio-Agusti et al. Neurology. 2011.
Abstract
Objective: We studied a case series of peripheral nerve hyperexcitability (PNH) aiming to describe clinical characteristics, immunologic and cancer associations, antibodies against neuronal antigens (voltage-gated potassium channel antibodies [VGKC-Abs] and other), and muscle biopsy findings.
Methods: Patients presenting with clinical and electrophysiologic signs of PNH were selected. We studied clinical and electrophysiologic features; a panel of non-neuronal organ-specific antibodies, immunofluorescence on rat nervous tissues, and radioimmunoprecipitation for VGKC-Abs; and muscle biopsies.
Results: Thirty-eight patients were included. After the exclusion of 6 cases with axonopathy of known origin, patients were subdivided according to the presence of electrophysiologic findings of motor axonopathy and association with cancer: axonopathic-PNH (group A: 12 patients), isolated nonparaneoplastic PNH (group B: 16 patients), and isolated paraneoplastic PNH (3 with thymoma and myasthenia gravis, 1 with thyroid carcinoma). PNH clinical features were similar in groups A and B. We found an overall high prevalence of clinical autoimmunity (33% of group A and 63% of group B) and systemic non-neuronal autoantibodies (42% of group A and 75% of group B). However, VGKC-Abs were only positive in 2 patients of group B. Ten patients underwent muscle biopsy, which showed inflammatory changes in 2 cases and nonspecific myopathic features in 8.
Conclusions: PNH is a heterogeneous disorder involving the peripheral nerves in patients with a high propensity for developing autoimmunity. Associated muscle diseases are frequent in the form of myositis, myasthenia gravis, or nonspecific myopathic pathologic findings. VGKC-Abs were uncommon in this series.
Similar articles
- Clinical spectrum of voltage-gated potassium channel autoimmunity.
Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Tan KM, et al. Neurology. 2008 May 13;70(20):1883-90. doi: 10.1212/01.wnl.0000312275.04260.a0. Neurology. 2008. PMID: 18474843 - Phenotypic variants of autoimmune peripheral nerve hyperexcitability.
Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Hart IK, et al. Brain. 2002 Aug;125(Pt 8):1887-95. doi: 10.1093/brain/awf178. Brain. 2002. PMID: 12135978 - Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy.
Heidenreich F, Vincent A. Heidenreich F, et al. Neurology. 1998 May;50(5):1483-5. doi: 10.1212/wnl.50.5.1483. Neurology. 1998. PMID: 9596015 - [Anti-VGKC antibody-associated limbic encephalitis/Morvan syndrome].
Misawa T, Mizusawa H. Misawa T, et al. Brain Nerve. 2010 Apr;62(4):339-45. Brain Nerve. 2010. PMID: 20420173 Review. Japanese. - [Immune-mediated neuromyotonia (Isaacs' syndrome)--clinical aspects and pathomechanism].
Arimura K, Watanabe O. Arimura K, et al. Brain Nerve. 2010 Apr;62(4):401-10. Brain Nerve. 2010. PMID: 20420181 Review. Japanese.
Cited by
- Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.
Kraus PD, Wolff D, Grauer O, Angstwurm K, Jarius S, Wandinger KP, Holler E, Schulte-Mattler W, Kleiter I. Kraus PD, et al. PLoS One. 2012;7(9):e44922. doi: 10.1371/journal.pone.0044922. Epub 2012 Sep 17. PLoS One. 2012. PMID: 23028681 Free PMC article. - Current Treatment Options for Peripheral Nerve Hyperexcitability Syndromes.
Elangovan C, Morawo A, Ahmed A. Elangovan C, et al. Curr Treat Options Neurol. 2018 May 28;20(7):23. doi: 10.1007/s11940-018-0510-9. Curr Treat Options Neurol. 2018. PMID: 29808385 Review. - Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis.
Torres-Vega E, Mancheño N, Cebrián-Silla A, Herranz-Pérez V, Chumillas MJ, Moris G, Joubert B, Honnorat J, Sevilla T, Vílchez JJ, Dalmau J, Graus F, García-Verdugo JM, Bataller L. Torres-Vega E, et al. Neurology. 2017 Mar 28;88(13):1235-1242. doi: 10.1212/WNL.0000000000003778. Epub 2017 Mar 1. Neurology. 2017. PMID: 28251919 Free PMC article. - Anti-CASPR2-Antibody-Positive Isaacs' Syndrome Presenting with Myokymia, Neuropathic Pain, and Hyperhidrosis.
Kim H, Lim YM, Lee EJ, Kim HW, Ahn HS, Kim KK. Kim H, et al. J Clin Neurol. 2020 Oct;16(4):699-701. doi: 10.3988/jcn.2020.16.4.699. J Clin Neurol. 2020. PMID: 33029979 Free PMC article. No abstract available. - Clinical characteristics of autoimmune disorders in the central nervous system associated with myasthenia gravis.
Kimura K, Okada Y, Fujii C, Komatsu K, Takahashi R, Matsumoto S, Kondo T. Kimura K, et al. J Neurol. 2019 Nov;266(11):2743-2751. doi: 10.1007/s00415-019-09461-3. Epub 2019 Jul 24. J Neurol. 2019. PMID: 31342158
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical